Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

Jury Awards $150 Million in 1st AndroGel Trial in MDL

July 25, 2017 — A federal jury in Chicago has awarded $150 million to a man who suffered a heart attack after using AndroGel testosterone gel for four years. The lawsuit was filed by Jesse Mitchell, a man from Oregon who started taking AndroGel in 2008. At the time,...

Actemra FAQ

Information and answers to Frequently Asked Questions (FAQ) about Actemra side effects, lawsuits, and class action settlements. What You Can Do & How We Can Help The Schmidt Firm, PLLC is currently accepting Actemra induced injury cases in all 50 states. If you or...

Over 5,500 Risperdal Lawsuits in Philadelphia Mass-Tort

July 18, 2017 — There are now over 5,800 Risperdal lawsuits pending in the Philadelphia Court of Common Pleas accusing Johnson & Johnson of failing to warn about the risk of gynecomastia. Gynecomastia is a disfiguring side effect of Risperdal in which young boys...

Heartburn Drugs Linked to Greater Risk of Death: Study

July 6, 2017 — A new study has found up to a 50% increased risk of death for long-term users of heartburn medications in the Proton Pump Inhibitor (PPI) class, such as Nexium and Prilosec. The study was published in BMJ Open by Dr. Ziyad Al-Aly of the U.S. Department...

Invokana Doubles Ketoacidosis Risk, Study Finds

June 22, 2017 — Invokana and similar diabetes drugs double the risk of ketoacidosis compared to DPP-4 inhibitor diabetes drugs, according to a study in the New England Journal of Medicine. It is the largest study to compare the risk of diabetic ketoacidosis (DKA), a...

Ex-FDA Testifies AndroGel Testosterone Gel Sold Off-Label

June 9, 2017 — Dr. David Kessler, former Commissioner of the FDA, testified that he believes AbbVie illegally marketed AndroGel testosterone gel for “off-label” uses, according to Law360.. In the first “bellwether” trial out of more than 4,200...